Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diagnostic Imaging

Free Subscription Articles published in Lancet Retrieve available abstracts of 65 articles: HTML format

Single Articles

October 2026
1. SARRAJ A, Costalat V, Zaidat OO, Yoshimura S, et al
   Beyond imaging thresholds in large-core stroke thrombectomy - Authors' reply.
   Lancet. 2026;408:1702-1703.
   PubMed    
   
   
   
2. BAKHRIANSYAH J, Baharuddin B, Prawitasari DS, Handayani L, et al
   Beyond imaging thresholds in large-core stroke thrombectomy.
   Lancet. 2026;408:1701.
   PubMed    
   
   
   August 2026
3. HARADA-SHOJI N, Suzuki A, Ishida T, Yamamoto S, et al
   Adjunctive ultrasonography in breast cancer screening: the J-START trial - Authors' reply.
   Lancet. 2026;408:697-698.
   PubMed    
   
   
   
4. FUSHIMI A
   Adjunctive ultrasonography in breast cancer screening: the J-START trial.
   Lancet. 2026;408:697.
   PubMed    
   
   
   
5. JING S, Song J
   Adjunctive ultrasonography in breast cancer screening: the J-START trial.
   Lancet. 2026;408:696-697.
   PubMed    
   
   
   
6. MACIOS A, Bretthauer M, Kalager M
   Adjunctive ultrasonography in breast cancer screening: the J-START trial.
   Lancet. 2026;408:696.
   PubMed    
   
   
   July 2026
7. SHINAMAN G, Lewandowski E, Wozniak G, Guo J, et al
   A case of acute necrotising encephalitis secondary to human herpesvirus 6 infection.
   Lancet. 2026;408:183-186.
   PubMed     Abstract available
   
   
   June 2026
8. GOMMERS J, Hernstrom V, Josefsson V, Sartor H, et al
   AI-supported mammography screening: measuring benefit - Authors' reply.
   Lancet. 2026;407:2605-2606.
   PubMed    
   
   
   
9. JENA PK, Shukla S, Pinnamaneni R
   AI-supported mammography screening: measuring benefit.
   Lancet. 2026;407:2605.
   PubMed    
   
   
   
10. CHU Y, Niu C, Jin W
    AI-supported mammography screening: measuring benefit.
    Lancet. 2026;407:2604.
    PubMed    
    
    
    
11. SILIPIGNI S, Soraci L, Gembillo G
    AI-supported mammography screening: measuring benefit.
    Lancet. 2026;407:2603-2604.
    PubMed    
    
    
    May 2026
12. GIOVANNONI G, Airas L, Bove R, Cutter GR, et al
    Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
    Lancet. 2026;407:2195-2207.
    PubMed     Abstract available
    
    
    
13. THERRIAULT J
    Advancing tau-PET imaging in Alzheimer's disease.
    Lancet. 2026;407:2148-2149.
    PubMed    
    
    
    
14. LEE JM, Lee SH, Gim DH, Lee SY, et al
    Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea.
    Lancet. 2026 May 21:S0140-6736(26)00666-5. doi: 10.1016/S0140-6736(26)00666.
    PubMed     Abstract available
    
    
    
15. SARRAJ A, Thomalla G, Yoshimura S, Huo X, et al
    Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.
    Lancet. 2026 May 7:S0140-6736(26)00876-7. doi: 10.1016/S0140-6736(26)00876.
    PubMed     Abstract available
    
    
    April 2026
16. GRAUPERA I, Thiele M, Castera L, Pera G, et al
    Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.
    Lancet. 2026;407:1448-1458.
    PubMed     Abstract available
    
    
    
17. VAN DER BIJL P, Bax JJ
    Contemporary non-invasive imaging for coronary artery disease - Authors' reply.
    Lancet. 2026;407:1425.
    PubMed    
    
    
    
18. HUNYOR I, Wilcox I, O'Sullivan J
    Contemporary non-invasive imaging for coronary artery disease.
    Lancet. 2026;407:1424.
    PubMed    
    
    
    
19. ZHENG H
    Contemporary non-invasive imaging for coronary artery disease.
    Lancet. 2026;407:1424.
    PubMed    
    
    
    
20. TOPOL EJ
    Mammography should include artificial intelligence support.
    Lancet. 2026;407:1415.
    PubMed    
    
    
    
21. HOLCK EN, Holm NR, Hildick-Smith D, Lindsay MM, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.
    Lancet. 2026;407:1374-1382.
    PubMed     Abstract available
    
    
    March 2026
22. ZHU Y, Cheng Z, Zhao Y, Han L, et al
    Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-
    Lancet. 2026;407:1161-1170.
    PubMed     Abstract available
    
    
    February 2026
23. HARADA-SHOJI N, Suzuki A, Ishida T, Yamamoto S, et al
    Cumulative incidence of advanced breast cancer in women aged 40-49 years in the Japan Strategic Anti-cancer Randomised Trial (J-START) of adjunctive ultrasonography: a prespecified secondary analysis.
    Lancet. 2026;407:784-793.
    PubMed     Abstract available
    
    
    
24. SEELY JM, Gordon PB
    Supplemental ultrasound screening lowers advanced breast cancers.
    Lancet. 2026;407:737-738.
    PubMed    
    
    
    January 2026
25. GOMMERS J, Hernstrom V, Josefsson V, Sartor H, et al
    Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy tria
    Lancet. 2026;407:505-514.
    PubMed     Abstract available
    
    
    December 2025
26. GOADSBY J, Syngelaki A, Magee LA, von Dadelszen P, et al
    Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial.
    Lancet. 2025 Dec 4:S0140-6736(25)01207-3. doi: 10.1016/S0140-6736(25)01207.
    PubMed     Abstract available
    
    
    November 2025
27. VAN DER BIJL P, Gulati M, Saraste A, Marwick T, et al
    Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease.
    Lancet. 2025;406:2577-2587.
    PubMed     Abstract available
    
    
    May 2025
28. GILBERT FJ, Payne NR, Allajbeu I, Yit L, et al
    Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial.
    Lancet. 2025 May 21:S0140-6736(25)00582-3. doi: 10.1016/S0140-6736(25)00582.
    PubMed     Abstract available
    
    
    
29. HOUSSAMI N
    Breast cancer screening at a crossroads: supplemental imaging for dense breasts.
    Lancet. 2025 May 21:S0140-6736(25)00803-7. doi: 10.1016/S0140-6736(25)00803.
    PubMed    
    
    
    March 2025
30. SERRUYS PW, Tsai TY, Revaiah PC
    Achieve more with less metal in PCI: angiography-derived FFR, intravascular ultrasound, or both?
    Lancet. 2025 Mar 28:S0140-6736(25)00576-8. doi: 10.1016/S0140-6736(25)00576.
    PubMed    
    
    
    
31. HU X, Zhang J, Yang S, Jiang J, et al
    Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00504-5. doi: 10.1016/S0140-6736(25)00504.
    PubMed     Abstract available
    
    
    
32. FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al
    Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505.
    PubMed     Abstract available
    
    
    
33. ELIA-ZUDAIRE O, Tirado-Galindo M
    Towards a European imaging infrastructure for Alzheimer's disease.
    Lancet. 2025;405:779.
    PubMed    
    
    
    February 2025
34. ARGENTESI G, Wu X, Ney A, Goodchild E, et al
    Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial.
    Lancet. 2025 Feb 7:S0140-6736(24)02755-7. doi: 10.1016/S0140-6736(24)02755.
    PubMed     Abstract available
    
    
    
35. DUNN JA, Donnelly P, Elbeltagi N, Marshall A, et al
    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial.
    Lancet. 2025;405:396-407.
    PubMed     Abstract available
    
    
    January 2025
36. WILLIAMS MC, Wereski R, Tuck C, Adamson PD, et al
    Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
    Lancet. 2025;405:329-337.
    PubMed     Abstract available
    
    
    
37. VILLINES TC
    Durability of patient benefit from CT-guided chest pain management.
    Lancet. 2025;405:278-279.
    PubMed    
    
    
    
38. NAVARRO-COMPAN V, Sepriano A, Capelusnik D, Baraliakos X, et al
    Axial spondyloarthritis.
    Lancet. 2025;405:159-172.
    PubMed     Abstract available
    
    
    October 2024
39. ANDERSEN BK, Sejr-Hansen M, Maillard L, Campo G, et al
    Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.
    Lancet. 2024 Oct 29:S0140-6736(24)02175-5. doi: 10.1016/S0140-6736(24)02175.
    PubMed     Abstract available
    
    
    August 2024
40. CASADO-NARANJO I, Portilla-Cuenca JC, Duarte-Martin JJ, Moyano-Calvente SL, et al
    Multiple intracerebral haemorrhages and ubiquitous brain microbleeds in a patient with Down syndrome: cerebral amyloid angiopathy.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
41. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
    Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
    PubMed     Abstract available
    
    
    
42. MAMAS MA, Mintz GS
    Optical coherence tomography imaging for complex percutaneous coronary intervention.
    Lancet. 2024 Aug 30:S0140-6736(24)01593-9. doi: 10.1016/S0140-6736(24)01593.
    PubMed    
    
    
    
43. FIGUERAS F, Rial-Crestelo M, Gratacos E
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial - Authors' reply.
    Lancet. 2024;404:751-752.
    PubMed    
    
    
    
44. GILES-CLARK HJ, Rolnik DL, Hodges RJ, Skinner SM, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:750.
    PubMed    
    
    
    
45. BACON I, Hezelgrave NL, Cerdeira AS, Mylrea-Foley B, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:750-751.
    PubMed    
    
    
    
46. KAMIHARA Y, Nagase H, Ishikawa H
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:749-750.
    PubMed    
    
    
    
47. MEIJERINK L, Terstappen F, Depmann M, Bekker M, et al
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:749.
    PubMed    
    
    
    
48. BORNSTEIN E, Vintzileos A
    Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
    Lancet. 2024;404:748-749.
    PubMed    
    
    
    
49. FERREIRA J, Velazquez PP, Zaromytidou M, Montrasio G, et al
    Fibrofatty involution of rhabdomyomas: a longitudinal series of cardiac MRI studies in a patient with possible tuberous sclerosis complex.
    Lancet. 2024;404:692-693.
    PubMed    
    
    
    
50. MESSAS E, Ijsselmuiden A, Trifunovic-Zamaklar D
    Limitations of non-invasive ultrasound therapy for valve stenosis - Authors' reply.
    Lancet. 2024;404:654.
    PubMed    
    
    
    
51. KOMAMURA K, Miyake H, Kobayashi K, Iwase M, et al
    Limitations of non-invasive ultrasound therapy for valve stenosis.
    Lancet. 2024;404:653-654.
    PubMed    
    
    
    
52. OU D, Hu C, Huang S
    Limitations of non-invasive ultrasound therapy for valve stenosis.
    Lancet. 2024;404:653.
    PubMed    
    
    
    July 2024
53. LI M, Kim JB, Sastry BKS, Chen M, et al
    Infective endocarditis.
    Lancet. 2024;404:377-392.
    PubMed     Abstract available
    
    
    
54. BHIDE P, Chan DYL, Lanz D, Alqawasmeh O, et al
    Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT): a multicentre, three-parallel-group, double-blind, randomised controlled trial.
    Lancet. 2024;404:256-265.
    PubMed     Abstract available
    
    
    May 2024
55. DE OLIVEIRA FRANCO A, Uberti Dos Santos V, von Ameln Lovison O, Zavascki AP, et al
    Invasive liver abscess syndrome with central nervous system involvement caused by hypermucoviscous Klebsiella pneumoniae: positive string test.
    Lancet. 2024;403:2257-2258.
    PubMed    
    
    
    
56. TOPOL EJ
    AI-enabled opportunistic medical scan interpretation.
    Lancet. 2024;403:1842.
    PubMed    
    
    
    
57. PONSSEN D, Joseph AA, Neef NE, Frahm J, et al
    Visualising the dynamic morphology of stuttering using real-time MRI.
    Lancet. 2024;403:1789-1790.
    PubMed    
    
    
    April 2024
58. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    PubMed     Abstract available
    
    
    
59. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    PubMed    
    
    
    March 2024
60. RAKOCZY EP
    The promise of long-term treatment for neovascular age-related macular degeneration.
    Lancet. 2024 Mar 27:S0140-6736(24)00428-8. doi: 10.1016/S0140-6736(24)00428.
    PubMed    
    
    
    
61. BURKI T
    Research in Focus: Gates MRI.
    Lancet. 2024;403:1126.
    PubMed    
    
    
    
62. CHEW EY
    Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration.
    Lancet. 2024 Mar 7:S0140-6736(24)00229-0. doi: 10.1016/S0140-6736(24)00229.
    PubMed    
    
    
    
63. GABRIELLE PH, Creuzot-Garcher C
    Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
    Lancet. 2024 Mar 7:S0140-6736(23)02760-5. doi: 10.1016/S0140-6736(23)02760.
    PubMed    
    
    
    February 2024
64. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
    PubMed    
    
    
    
65. STONE GW, Christiansen EH, Ali ZA, Andreasen LN, et al
    Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
    Lancet. 2024 Feb 21:S0140-6736(23)02454-6. doi: 10.1016/S0140-6736(23)02454.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum